Amgen Inc. buy phonebroker
Start price
29.04.21
/
40%
€196.62
Target price
29.04.22
€217.00
Performance (%)
-3.11%
End price
23.08.21
€190.50
Summary
This prediction ended on 23.08.21 with a price of €190.50. With a performance of -3.11%, the BUY prediction for Amgen Inc. by phonebroker closed slightly in the red. Dividends of €2.95 are taken into consideration when calculating the performance. phonebroker has 40% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Amgen Inc. | -1.016% | -1.016% | 23.168% | 54.840% |
iShares Core DAX® | 1.937% | 1.473% | 18.596% | 15.757% |
iShares Nasdaq 100 | -1.186% | -0.040% | 27.123% | 35.363% |
iShares Nikkei 225® | 1.938% | 4.205% | 17.502% | 10.532% |
iShares S&P 500 | -0.023% | 0.109% | 24.843% | 36.692% |
Comments by phonebroker for this prediction
In the thread Amgen Inc. diskutieren
Buy Amgen Inc.
Kursziel gesetzt auf 217,0
In the thread Trading Amgen Inc.
Buy beendet